This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Charles River Laboratories International In (CRL)

NYSE: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 117.95M 160.02M 155.93M 109.69M
Receivables 270.07M 257.99M 220.63M 206.33M
Inventories 93.73M 89.04M 89.40M 88.47M
Other Current Assets 47.29M 16.46M 11.91M 73.99M
Total Current Assets 559.23M 606.90M 552.55M 485.25M
Property, Plant & Equipment, Gross 677.96M 1.33B 1.32B 1.31B
Accumulated Depreciation & Depletion n.a. 654.98M 645.53M 595.99M
Property, Plant & Equipment, Net 677.96M 676.80M 676.18M 717.02M
Intangibles 280.80M 178.88M 84.54M 84.92M
Other Non-Current Assets 71.64M 78.35M 65.11M 51.99M
Total Non-Current Assets 1.51B 1.28B 1.09B 1.10B
Liabilities & Shareholder Equity
Total Assets 2.07B 1.89B 1.64B 1.59B
Accounts Payable 36.67M 33.81M 31.77M 31.22M
Short Term Debt 17.03M 31.90M 21.44M 139.38M
Other Current Liabilities 14.38M 11.66M 20.70M 20.02M
Total Current Liabilities 311.76M 296.17M 247.03M 342.25M
Long Term Debt 846.00M 745.96M 642.35M 527.14M
Deferred Income Taxes 48.22M 30.82M 0.00 0.00
Other Non-Current Liabilities 124.96M 136.32M 90.58M 113.76M
Minority Interest 1.77M 1.50M 1.32M 571.00K
Total Non-Current Liabilities 1.02B 916.82M 756.60M 643.29M
Total Liabilities 1.34B 1.21B 1.00B 985.54M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 733.07M 672.20M 640.98M 600.80M
Common Par n.a. 845.00K 825.00K 796.00K
Additional Paid In Capital 0.00 2.31B 2.21B 2.10B
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 -138.78M -265.47M -368.30M
Treasury Stock n.a. -1.42B -1.31B -1.14B
Other Equity Adjustments 733.07M -74.25M 5.36M 6.60M
Total Capitalization 1.58B 1.42B 1.28B 1.13B
Total Equity 733.07M 672.20M 640.98M 600.80M
Total Liabilities & Stock Equity 2.07B 1.89B 1.64B 1.59B
Total Common Shares Outstanding 46.62M 47.33M 47.55M 48.22M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 37.18M 34.97M 31.39M
Basic Weighted Shares Outstanding 46.50M 46.63M 47.74M 47.91M
Diluted Weighted Shares Outstanding 47.63M 47.56M 48.49M 48.41M
Number of Employees NA 7900 7700 7200
Number of Part-Time Employees NA 0 0 0
CRL News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

CRL Charles River Laboratories International In

Chart of CRL

Analysts Ratings for CRL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 6 6
Moderate Buy 0 0 0 0
Hold 5 5 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET CRL ANALYST REPORT

CRL Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs